Author(s): Shukla R, Sasseville D
BACKGROUND: The management of psychodermatologic disease often involves the use of psychotropics by dermatologists. A general approach to the psychopharmacologic management of psychodermatological disease may be of assistance to the dermatologist.
OBJECTIVE: We review and provide a current psychopharmacologically based approach to management of common psychopathologies associated with psychodermatologic disorders, common side effects, and potential drug interactions that may occur with selected psychotropics.
METHODS: Using relevant MeSH terms, we performed a review of the literature from 1980 to 2006.
RESULTS AND CONCLUSIONS: Effective psychopharmacologic management of psychodermatologic disease involves identifying and basing treatment on the associated psychopathology; familiarity with a variety of psychotropic agents, including antidepressants, anxiolytics, and antipsychotics; and the involvement of a psychiatrist when possible.
Dermatology Journal and/or Publisher
Journal Name: Journal of cutaneous medicine and surgery
Journal Abbreviation: J Cutan Med Surg
Journal Date Published: 2009-03-25
National Center for Biotechnology Information
PMID: 19317947
Article Source: http://www.ncbi.nlm.nih.gov/pubmed/19317947
Lasted Revision: 2017-02-14
Abstract Source: National Center for Biotechnology Information, U.S. National Library of Medicine Abstract Query for Hidradenitis suppurativa (HS).
Tags: Mental Health Psychodermatology Psychology
